المؤلفون: Diego A. Pereira‐Martins, Juan L. Coelho‐Silva, Isabel Weinhäuser, Pedro L. Franca‐Neto, Douglas R. Silveira, César Ortiz, Amanda Moreira‐Aguiar, Marinus M. Lima, Luisa C. Koury, Raul A. de Melo, Ana B. Glória, Evandro M. Fagundes, Bruno K. Lino, Katia Pagnano, Rosane Bittencourt, Elenaide Nunes, Fabiola Traina, Lorena Figueiredo‐Pontes, Armand Keating, Martin S. Tallman, Raul C. Ribeiro, Richard Dilon, Arnold Ganser, Miguel A. Sanz, Nancy Berliner, Peter Valk, Bob Löwenberg, Tiziana Ottone, Nelida I. Noguera, Maria T. Voso, Francesca Paoloni, Paola Fazi, Emanuele Ammatuna, Gerwin Huls, Jan Jacob Schuringa, Eduardo M. Rego, Antonio R. Lucena‐Araujo

المساهمون: Hematology, Stem Cell Aging Leukemia and Lymphoma (SALL), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: British Journal of Haematology, 200(2), 170-174. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 200(2), 170-174. Wiley

مصطلحات موضوعية: RISK, anthracycline-based chemotherapy, mtDNA content, RETINOIC ACID, oxidative phosphorylation, RAR-ALPHA, Hematology, ATRA, Settore MED/15, ARSENIC TRIOXIDE

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d4c4270bd170e7b621c9553c38e646
https://pure.eur.nl/en/publications/0c0bdef6-9f6c-4fba-ba95-d694023e4b02